Literature DB >> 6144607

Insulin receptor regulation and desensitization in rat hepatoma cells. Concomitant changes in receptor number and in binding affinity.

M Crettaz, C R Kahn.   

Abstract

We have studied the effects of chronic exposure to insulin on the binding and the biologic activity of the hormone using a well-differentiated cell line (Fao) derived from the Reuber H35 rat hepatoma. Prolonged incubation (24 h) with 10(-6) M insulin produced a 20-25% decrease in binding of tracer concentrations (2 X 10(-11) M) of 125I-insulin, and a leftward shift of the curve for inhibition by unlabeled insulin. Scatchard analysis of the binding data revealed that a 75-80% decrease in the number of binding sites had occurred in the insulin-treated cells, but was accompanied by an increase in apparent receptor affinity. Kinetic studies suggested negative cooperativity in insulin binding and indicated that the change in affinity was accounted for by a decrease in the rate of dissociation. Both the decrease in receptor number and the increase in affinity were dependent on time, temperature, and the insulin concentration during the treatment period. Both effects were also blocked by cycloheximide, suggesting that they required new protein synthesis. Plasma membranes isolated from downregulated cells retained both the change in receptor number and affinity. Anti-receptor antibodies present in two human sera (B-2 and B-9) inhibited 125I-insulin binding in downregulated cells with equal or slightly greater sensitivity than in control cells. The changes in insulin binding were accompanied by changes in insulin's biologic effects in these cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6144607     DOI: 10.2337/diab.33.5.477

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  12 in total

1.  Defective glucose utilization in patients with functioning beta-cell tumors persists after tumor excision.

Authors:  G S McGee; M M Kulaylat; N N Abumrad
Journal:  Ann Surg       Date:  1987-10       Impact factor: 12.969

2.  Substitution of the erbB-2 oncoprotein transmembrane domain activates the insulin receptor and modulates the action of insulin and insulin-receptor substrate 1.

Authors:  B Cheatham; S E Shoelson; K Yamada; E Goncalves; C R Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

3.  Metformin enhances certain insulin actions in cultured rat hepatoma cells.

Authors:  F Purrello; D Gullo; M Buscema; V Pezzino; R Vigneri; I D Goldfine
Journal:  Diabetologia       Date:  1988-06       Impact factor: 10.122

4.  Insulin receptor desensitization correlates with attenuation of tyrosine kinase activity, but not of receptor endocytosis.

Authors:  A D Blake; N S Hayes; E E Slater; C D Strader
Journal:  Biochem J       Date:  1987-07-15       Impact factor: 3.857

5.  A unique receptor-independent mechanism by which insulinlike growth factor I regulates the availability of insulinlike growth factor binding proteins in normal and transformed human fibroblasts.

Authors:  C A Conover
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

6.  Insulin receptor down-regulation is linked to an insulin-induced postreceptor defect in the glucose transport system in rat adipocytes.

Authors:  W T Garvey; J M Olefsky; S Marshall
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

7.  Growth stimulation of primary rat hepatocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  D Wölfle; E Becker; C Schmutte
Journal:  Cell Biol Toxicol       Date:  1993 Jan-Mar       Impact factor: 6.691

8.  Endoplasmic reticulum stress causes insulin resistance by inhibiting delivery of newly synthesized insulin receptors to the cell surface.

Authors:  Max Brown; Samantha Dainty; Natalie Strudwick; Adina D Mihai; Jamie N Watson; Robina Dendooven; Adrienne W Paton; James C Paton; Martin Schröder
Journal:  Mol Biol Cell       Date:  2020-09-02       Impact factor: 4.138

9.  Insulin-induced activation of phosphoinositide 3-kinase in Fao cells.

Authors:  T Hayashi; M Okamoto; Y Yoshimasa; G Inoue; K Yamada; S Kono; M Shigemoto; J Suga; H Kuzuya; K Nakao
Journal:  Diabetologia       Date:  1996-05       Impact factor: 10.122

10.  PI3-kinase mutation linked to insulin and growth factor resistance in vivo.

Authors:  Jonathon N Winnay; Marie H Solheim; Ercument Dirice; Masaji Sakaguchi; Hye-Lim Noh; Hee Joon Kang; Hirokazu Takahashi; Kishan K Chudasama; Jason K Kim; Anders Molven; C Ronald Kahn; Pål R Njølstad
Journal:  J Clin Invest       Date:  2016-03-14       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.